Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model

Overview of attention for article published in BMC Cancer, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

SUBSTANCE INTERACTING WITH C TERMINAL FRAGMENT OF THE STIM1 FRACTION LOCALIZED TO THE…

Application WO-2020193450-A1

World Intellectual Property Organisation (WIPO)

SUBSTANCE INTERACTING WITH C TERMINAL FRAGMENT OF THE STIM1 FRACTION LOCALIZED TO THE…

Application EP-3715848-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.